Concourse Financial Group Securities, Inc. Altimmune, Inc. Transaction History
Concourse Financial Group Securities, Inc.
- $1.56 Billion
- Q2 2024
A detailed history of Concourse Financial Group Securities, Inc. transactions in Altimmune, Inc. stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 100 shares of ALT stock, worth $757. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100
Previous 100
-0.0%
Holding current value
$757
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding ALT
# of Institutions
191Shares Held
42.4MCall Options Held
1.05MPut Options Held
582K-
Black Rock Inc. New York, NY5.32MShares$40.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.91MShares$37.1 Million0.0% of portfolio
-
State Street Corp Boston, MA3.91MShares$29.6 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN3.22MShares$24.4 Million0.01% of portfolio
-
Tang Capital Management LLC San Diego, CA2.75MShares$20.8 Million2.23% of portfolio
About Altimmune, Inc.
- Ticker ALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,025,300
- Market Cap $371M
- Description
- Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...